生长激素促分泌剂受体 growth hormone secretagogues receptor
促分泌剂 secretagogue
胰岛素促泌剂 insulin secretagogues
尿分泌抑制剂 antidiuretic
分泌酶抑制剂 DAPT ; Secretase inhibitor ; gamma-secretase inhibitors
胰岛素分泌促进剂 Promoter to Insulin Secretion
内分泌干扰剂 endocrine disrupters
胰岛素分泌模式调节剂 insulin secretion pattern regulators
胰泌素试剂盒 Human Secretin ELISA KIT
泌乳素抑制剂 prolactin inhibitor
胰岛素促泌剂是目前治疗2型糖尿病的一类主要口服降糖药，是非肥胖及部分肥胖2型糖尿病的一线治疗药物。
Insulin secretagogues presently is not only a kind of major oral hypoglycemic drugs but also the first-line treatment for non-obese and obese type 2 diabetic mellitus(T2DM).
百泌达是FDA批准的治疗2型糖尿病的首个GLP - 1受体激动剂药物。
BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.
GLP - 1分泌增加是通过人工甜味剂刺激L细胞上的甜味受体调节的。
This increase in GLP-1 secretion may be mediated via stimulation of sweet-taste receptors on L-cells by artificial sweetener.
应用推荐